452 related articles for article (PubMed ID: 18067212)
1. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
2. Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study.
Chandrashekar NS; Hiremath SR
Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):235-9. PubMed ID: 18221066
[TBL] [Abstract][Full Text] [Related]
3. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.
Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY
Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907
[TBL] [Abstract][Full Text] [Related]
5. Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice.
Rashidi B; An Z; Sun FX; Moossa AR; Hoffman RM
Clin Cancer Res; 2000 Jun; 6(6):2464-8. PubMed ID: 10873100
[TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
7. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study.
Menei P; Venier MC; Gamelin E; Saint-André JP; Hayek G; Jadaud E; Fournier D; Mercier P; Guy G; Benoit JP
Cancer; 1999 Jul; 86(2):325-30. PubMed ID: 10421269
[TBL] [Abstract][Full Text] [Related]
8. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
9. [Microemulsion-based gel of fluorouracil for transdermal delivery].
Xiao YY; Liu F; Chen ZP; Ping QN
Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
[TBL] [Abstract][Full Text] [Related]
10. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
Hao X; Cheng G; Zou M; Sun J; Cui F
Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of 5-fluorouracil from transdermal patches on EAC and DLA cell-induced tumors in mice.
Chandrashekar NS; Prasanth VV
Asian Pac J Cancer Prev; 2008; 9(3):437-40. PubMed ID: 18990017
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
[TBL] [Abstract][Full Text] [Related]
13. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
14. [Injectable bioerodible polymer with 5-fluorouracil used in filtration surgery in rabbits].
Xu Y; Yang G; Jin W
Zhonghua Yan Ke Za Zhi; 1997 May; 33(3):184-8. PubMed ID: 10437031
[TBL] [Abstract][Full Text] [Related]
15. 5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
Di Paolo A; Lencioni M; Amatori F; Di Donato S; Bocci G; Orlandini C; Lastella M; Federici F; Iannopollo M; Falcone A; Ricci S; Del Tacca M; Danesi R
Clin Cancer Res; 2008 May; 14(9):2749-55. PubMed ID: 18451241
[TBL] [Abstract][Full Text] [Related]
16. [Relationships between tumor shrinkage and peripheral blood cell changes during tumor-rejection induced by a high dose of 5-FU in C57BL/6 mice].
Li CG; Li ML; Shu XH; Liu YJ; Michael N; Qin ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Feb; 24(2):156-8. PubMed ID: 18237534
[TBL] [Abstract][Full Text] [Related]
17. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
18. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
20. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
